Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs (Find 426 items)

Circulatory System Drugs

Vildagliptin

(274901-16-5)
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes me

Product List

Request for quotation , get quotes from more suppliers.

Atorvastatin calcium

(134523-03-8)
1. A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia
2. A selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
3. Antihyperlipidemic, HMGCoA reductase inhibitor
4. DMSO an

Product List

Request for quotation , get quotes from more suppliers.

Chondroitin 4-sulfate

(24967-93-9)
Used for coronary atherosclerotic diseases, increased blood lipids and cholesterol, arteriosclerosis, angina pectoris, myocardial ischemia, myocardial infarction and other diseases.

Product List

Request for quotation , get quotes from more suppliers.

Chondroitin sulfate

(9007-28-7)
Chondroitin sulfate is described as a skin-conditioning agent, with possible anti-inflammatory properties. It can be found in such products as moisturizers and night skin care preparations. It is a derivative of natural mucopolysaccharides.

Product List

Request for quotation , get quotes from more suppliers.

Oleuropein

(32619-42-4)
Oleuropein is a tyrosol ester derivative of elenolic acid and phenolic glycoside found in olive oil. Oleuropein shows antioxidant, anti-ischemic and hypolipidemic activity. Oleuropein has also been used as an immunomodulator .

Product List

Request for quotation , get quotes from more suppliers.

Telmisartan

(144701-48-4)
1. Cardiotonic
2. Telmisartan is an angiotensin II receptor antagonist.
3. Anti-cancer agent
4. Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart

Product List

Request for quotation , get quotes from more suppliers.

Pitavastatin calcium

(147526-32-7)
Pitavastatin Calcium is a competitive inhibitor of the enzyme HMGCR. Alternate studies show that pitavastatin can suppress oxygen production in endothelial cells by inhibiting Nox. In addition, pitavastatin reduces the expression of eNOS mRNA while increasing the NO dependent response stimulated by acetylcholine and the calcium ionophore,A23187.

Product List

Request for quotation , get quotes from more suppliers.

Vinpocetine

(42971-09-5)
1. A calcium/calmodulin-dependent phosphodiesterase 1 (PDE1) inhibitor
2. A derivative of Vincamine with vasodilating activity. Vasodilator (cerebral).
3. Calcium regulator
4. Gleevec metabolite, tyrosine kinase inhibitor

Product List

Request for quotation , get quotes from more suppliers.

Sitagliptin

(486460-32-6)
Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug used to treat type II diabetes. Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs. It improves the ability of diabetic patients' own pancreatic β cells to produce insulin and increases insulin secretion when blood sugar rises, thereby controlling the blood sugar level of diabetic patients. Clinical studies have shown that sitagliptin

Product List

News

Request for quotation , get quotes from more suppliers.

Glabridin

(59870-68-7)
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols.It is used as an ingredient in cosmetics and is listed in International Nomenclature of Cosmetic Ingredients (INCI).Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.

Product List

Request for quotation , get quotes from more suppliers.

Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on ECHEMI covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.

Frequently Asked Questions

What are circulatory system drugs used for?

Circulatory system drugs are medications designed to treat conditions affecting the heart and blood vessels. They are commonly used to manage hypertension (high blood pressure), heart failure, arrhythmias, angina, and to prevent blood clots. These drugs help regulate blood flow, reduce cardiac workload, and improve overall cardiovascular function, playing a critical role in both acute and chronic cardiovascular care.

What are the main types of circulatory system medications?

The main types of circulatory system drugs include:1. Antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) for lowering blood pressure.2. Antiarrhythmics to stabilize irregular heart rhythms.3. Vasodilators that widen blood vessels to improve blood flow.4. Anticoagulants and antiplatelets (e.g., warfarin, aspirin) to prevent clot formation.5. Diuretics to reduce fluid buildup and lower blood pressure.Each class targets specific mechanisms within the cardiovascular system to achieve therapeutic effects.

How do I choose a reliable supplier for circulatory system APIs?

To choose a reliable supplier for circulatory system active pharmaceutical ingredients (APIs), consider the following criteria:1. Regulatory compliance—ensure the supplier holds certifications such as GMP, FDA approval, or EMA authorization.2. Quality assurance—verify robust testing protocols, documentation (e.g., COA, DMF), and traceability of raw materials.3. Manufacturing consistency—assess batch-to-batch reproducibility and scalability.4. Technical support and regulatory expertise to assist with global market requirements.Selecting a vetted, experienced API manufacturer minimizes risk and ensures drug safety and efficacy.

What quality standards apply to circulatory system drug intermediates?

Circulatory system drug intermediates must adhere to stringent quality standards to ensure final drug safety and performance. Key standards include compliance with ICH guidelines, GMP (Good Manufacturing Practice), and pharmacopeial specifications (e.g., USP, EP). Impurity profiles, residual solvents, and structural identity must be rigorously controlled. Reputable manufacturers conduct comprehensive analytical testing (HPLC, GC, NMR) and maintain full documentation for regulatory submissions.

Are there common side effects associated with circulatory system medications?

Yes, circulatory system drugs may cause side effects depending on the drug class. For example:- Beta-blockers can lead to fatigue, cold extremities, or bradycardia.- ACE inhibitors may cause a persistent dry cough or hyperkalemia.- Diuretics might result in electrolyte imbalances or dehydration.- Anticoagulants increase bleeding risk.Patients should always use these medications under medical supervision, and healthcare providers monitor for adverse reactions to optimize therapy safety and effectiveness.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.